Journal
FEMS MICROBIOLOGY LETTERS
Volume 261, Issue 2, Pages 181-186Publisher
OXFORD UNIV PRESS
DOI: 10.1111/j.1574-6968.2006.00350.x
Keywords
tuberculosis; chemotherapy; econazole; antitubercular drugs
Categories
Ask authors/readers for more resources
The present study was designed to evaluate the in vivo antimycobacterial potential of econazole alone and in combination with antitubercular drugs against tuberculosis in mice. Econazole was found to reduce bacterial burden by 90% in the lungs and spleen of mice infected with 1 x 10(7) cells of Mycobacterium tuberculosis and was found to be equipotent to rifampicin. Further, our results indicate that econazole can replace rifampicin/isoniazid as well as both rifampicin and isoniazid in chemotherapy of murine tuberculosis. Econazole alone or in combination with antitubercular drugs did not produce any hepatotoxicity in normal or M. tuberculosis-infected mice.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available